Guidance values for surface monitoring of antineoplastic drugs in german pharmacies

Annals of Occupational Hygiene

Volumn 53, Issue 7, 2009, Pages 703-711

  Schierl, Rudolf ^a   Böhlandt, Antje ^a   Nowak, Dennis ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fluorouracil; Hazardous drugs; Platinum

Indexed keywords

5-FLUOROURACIL; ANTI-CANCER THERAPIES; ANTINEOPLASTIC DRUGS; CONTAMINATION CONTROL; CONTAMINATION LEVELS; CYTOTOXIC ACTIVITIES; DATA SETS; FLUOROURACIL; GAS CHROMATOGRAPHY/MASS SPECTROMETRY; GERMANY; HAZARDOUS DRUGS; MEDIAN VALUE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PERSONAL EXPOSURES; STATISTICAL DESCRIPTIONS; SURFACE MONITORING; WORKING PRACTICES;

CONTAMINATION; OCCUPATIONAL RISKS; PHOTOTRANSISTORS; PLATINUM; POLLUTION DETECTION;

DRUG THERAPY;

ANTINEOPLASTIC AGENT; FLUOROURACIL; PLATINUM;

ARTICLE; CONTAMINATION; DRUG STORAGE; ENVIRONMENTAL MONITORING; GERMANY; HUMAN; MASS FRAGMENTOGRAPHY; MAXIMUM ALLOWABLE CONCENTRATION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PHARMACY; POTENTIOMETRY; PRIORITY JOURNAL; SAMPLING; SURFACE PROPERTY; THRESHOLD GUIDANCE VALUE; WORKPLACE;

ANTINEOPLASTIC AGENTS; DECONTAMINATION; ENVIRONMENTAL MONITORING; FLUOROURACIL; GERMANY; HUMANS; OCCUPATIONAL EXPOSURE; PHARMACIES; PLATINUM COMPOUNDS; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; WORKPLACE;

EID: 70350062577     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/mep050     Document Type: Article

References (36)

1. Brouwers EE, Huitema AD, Bakker EN et al. (2007) Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. Int Arch Occup Environ Health; 80: 689-699
2. Castiglia L, Miraglia N, Pieri M et al. (2008) Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department. J Occup Health; 50: 48-56.
3. Cocker J, Jones K, Morton J et al. (2007) Biomonitoring at the UK Health and Safety Laboratory. Int J Hyg Environ Health; 210: 383-386
4. Connor TH, Anderson RW, Sessink PJ et al. (1999) Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am J Health Syst Pharm; 56: 1427-1432
5. Crauste-Manciet S, Sessink PJ, Ferrari S et al. (2005) Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Ann Occup Hyg; 49: 619-628
6. Delporte J, Chenoix P, Hubert P. (1999) Chemical contamination of the primary packaging of 5-fluorouracil RTU solutions commercially available on the Belgian market. Eur Hosp Pharm; 5: 119-121
7. Dranitsaris G, Johnston M, Poirier S et al. (2005) Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract; 11: 69-78.
8. Ensslin AS, Pethran A, Schierl R et al. (1994) Urinary platinum in hospital personnel occupationally exposed to platinumcontaining antineoplastic drugs. Int Arch Occup Environ Health; 65: 339-342 (Pubitemid 24083182)
9. Falck K, Grohn P, Sorsa M et al. (1979) Mutagenicity in urine of nurses handling cytostatic drugs. Lancet; 1: 1250-1251
10. Favier B, Gilles L, Ardiet C et al. (2003) External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. J Oncol Pharm Pract; 9: 15-20.
11. Floridia L, Pietropaolo AM, Tavazzani M et al. (1999) Measurement of surface contamination from nucleoside analogue antineoplastic drugs by high-performance liquid chromatography in occupational hygiene studies of oncologic hospital departments. J Chromatogr B Biomed Sci Appl; 724: 325-334 (Pubitemid 29148094)
12. Fransman W, Peelen S, Hilhorst S et al. (2007) A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. Ann Occup Hyg; 51: 231-239 (Pubitemid 47355665)
13. FransmanW, Vermeulen R, Kromhout H. (2005) Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health; 78: 403-412
14. Funck S, Schierl R. (2004) Sicherheit bei der Zytostatikaherstellung [in German]. Deutsche Apotheker Zeitung; 144: 55-60.
15. Harrison BR, Peters BG, Bing MR. (2006) Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. Am J Health Syst Pharm; 63: 1736-1744
16. Hedmer M, Georgiadi A, Bremberg ER et al. (2005) Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Ann Occup Hyg; 49: 629-637
17. Heinemann A, Kiffmeyer T, Tuerk J et al. (2008) Monitoring- Effect-Study of Wipe Sampling in Pharmacies (MEWIP). Final report [in German]. In Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege, BGW. Cologne.
18. Heise A. (2006) Zubereitung von Zytostatika in Apotheken: Untersuchungen zur Arbeitsplatzkontamination [in German]; PhD Thesis. Munich, Germany: University Munich. http://edoc.ub.uni-muenchen.de/5962/1/Heise-Antje.pdf.
19. Hirst M, Tse S, Mills DG et al. (1984) Occupational exposure to cyclophosphamide. Lancet; 1: 186-188
20. IARC. (1987) IARC monographs on the evaluation of the carcinogenic risk to humans, supplement 7, overall evaluation of carcinogenicity: an updating of IARC monographs volumes 1-42. Lyon, France: International Agency for Research on Cancer.
21. IARC. (1997) Monographs on the evaluation of the carcinogenic risks of chemicals to humans: overall evaluations of carcinogenicity. Updation of IARC monographs volumes 1-42. Lyon, France: International Agency for Research on Cancer.
22. Kromhout H, Hoek F, Uitterhoeve R et al. (2000) Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg; 44: 551-560
23. Mason HJ, Blair S, Sams C et al. (2005) Exposure to antineoplastic drugs in two UK hospital pharmacy units. Ann Occup Hyg; 49: 603-610
24. Mason HJ, Morton J, Garfitt SJ et al. (2003) Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg; 47: 681-685
25. Micoli G, Turci R, Arpellini M et al. (2001) Determination of 5-fluorouracil in environmental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl; 750: 25-32.
26. Nygren O, Gustavsson B, Strom L et al. (2002) Cisplatin contamination observed on the outside of drug vials. Ann Occup Hyg; 46: 555-557
27. Pethran A, Schierl R, Hauff K et al. (2003) Uptake of antineoplastic agents in pharmacy and hospital personnel. Part monitoring of urinary concentrations. Int Arch Occup Environ Health; 76: 5-10. (Pubitemid 36740714)
28. Pharmacopeia. (2008) U.S. Usp Pharmacists' Pharmacopeia 2008, status and update to general chapter ,797. 2nd edn. Rockville, MD: American Society of Health-System Pharmacists.
29. Saurel-Cubizolles MJ, Job-Spira N, Estryn-Behar M. (1993) Ectopic pregnancy and occupational exposure to antineoplastic drugs. Lancet; 341: 1169-1171
30. Schmaus G, Schierl R, Funck S. (2002) Monitoring surface contamination by antineoplastic drugs using gas chromatography- mass spectrometry and voltammetry. Am J Health Syst Pharm; 59: 956-961
31. Sessink PJ, Anzion RB, Van den Broek PH et al. (1992) Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharm Weekbl Sci; 14: 16-22.
32. Sessink PJ, Van de Kerkhof MC, Anzion RB et al. (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health; 49: 165-169
33. Stuecker I, Caillard JF, Collin R et al. (1990) Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health; 16: 102-107
34. Turci R, Sottani C, Spagnoli G et al. (2003) Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J Chromatogr B Analyt Technol Biomed Life Sci; 789: 169-209.
35. Valanis B, VollmerW, Labuhn K et al. (1997) Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. J Occup Environ Med; 39: 574-580
36. Ziegler E, Mason HJ, Baxter PJ. (2002) Occupational exposure to cytotoxic drugs in two UK oncology wards. Occup Environ Med; 59: 608-612